SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $689,884 | -6.3% | 25,023 | +2.1% | 0.00% | 0.0% |
| Q2 2023 | $736,470 | -30.6% | 24,500 | -16.3% | 0.00% | 0.0% |
| Q1 2023 | $1,060,669 | +1.3% | 29,276 | -0.3% | 0.00% | 0.0% |
| Q4 2022 | $1,047,022 | +13.7% | 29,353 | +7.9% | 0.00% | 0.0% |
| Q3 2022 | $921,000 | +97.6% | 27,200 | +68.9% | 0.00% | 0.0% |
| Q2 2022 | $466,000 | +86.4% | 16,100 | +108.0% | 0.00% | – |
| Q1 2022 | $250,000 | -18.3% | 7,740 | -22.0% | 0.00% | – |
| Q2 2021 | $306,000 | -20.9% | 9,923 | -32.8% | 0.00% | – |
| Q1 2021 | $387,000 | -28.2% | 14,764 | -31.0% | 0.00% | – |
| Q4 2020 | $539,000 | -81.3% | 21,407 | -84.5% | 0.00% | -100.0% |
| Q3 2020 | $2,887,000 | -47.6% | 138,524 | -40.2% | 0.00% | -57.1% |
| Q2 2020 | $5,505,000 | +33.9% | 231,775 | +1.4% | 0.01% | +16.7% |
| Q1 2020 | $4,111,000 | +9.1% | 228,478 | +43.8% | 0.01% | +50.0% |
| Q4 2019 | $3,768,000 | +946.7% | 158,848 | +1112.6% | 0.00% | – |
| Q3 2019 | $360,000 | -62.7% | 13,100 | -52.4% | 0.00% | -100.0% |
| Q1 2019 | $965,000 | -45.1% | 27,535 | -48.0% | 0.00% | -50.0% |
| Q4 2018 | $1,757,000 | +418.3% | 52,902 | +614.9% | 0.00% | – |
| Q1 2018 | $339,000 | -31.7% | 7,400 | -40.6% | 0.00% | -100.0% |
| Q4 2017 | $496,000 | -3.5% | 12,457 | -3.1% | 0.00% | 0.0% |
| Q3 2017 | $514,000 | -30.8% | 12,852 | -25.5% | 0.00% | 0.0% |
| Q2 2017 | $743,000 | +31.7% | 17,248 | -4.2% | 0.00% | 0.0% |
| Q1 2017 | $564,000 | -1.1% | 18,008 | -20.3% | 0.00% | 0.0% |
| Q4 2016 | $570,000 | +67.6% | 22,594 | +64.3% | 0.00% | 0.0% |
| Q3 2016 | $340,000 | +7.9% | 13,754 | -11.1% | 0.00% | 0.0% |
| Q2 2016 | $315,000 | -6.2% | 15,473 | -29.7% | 0.00% | 0.0% |
| Q1 2016 | $336,000 | -3.4% | 22,010 | -15.1% | 0.00% | 0.0% |
| Q4 2015 | $348,000 | -69.0% | 25,925 | -67.6% | 0.00% | -50.0% |
| Q3 2015 | $1,124,000 | -44.1% | 80,088 | -32.4% | 0.00% | -33.3% |
| Q2 2015 | $2,011,000 | +1508.8% | 118,428 | +1048.8% | 0.00% | – |
| Q1 2015 | $125,000 | -60.2% | 10,309 | -72.7% | 0.00% | – |
| Q4 2014 | $314,000 | -47.3% | 37,798 | -44.9% | 0.00% | -100.0% |
| Q3 2014 | $596,000 | -56.9% | 68,543 | -45.7% | 0.00% | -50.0% |
| Q2 2014 | $1,383,000 | +1.5% | 126,285 | -17.2% | 0.00% | 0.0% |
| Q1 2014 | $1,363,000 | +454.1% | 152,442 | +354.2% | 0.00% | – |
| Q3 2013 | $246,000 | – | 33,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |